[1]
Nisijima K, Shirnizu M, Ishiguro T. Treatment of tardive dystonia with an antispastic agent. Acta Psychiatr Scand 1998; 98(4): 341-3.
[2]
Bose K. The efficacy and safety of eperisone in patients with cervical spondylosis: results of a randomized, double-blind, placebo-controlled trial. Method fined exp clin 1999; 21(3): 209-14.
[3]
Tanaka K, Kaneko T, Yamatsu K. Effects of 4'ethyl-
2-methyl-3 piperidinopropiophenone on experimental
rigidity and spinal cord activities (author's transl). Folia
pharmacologica Japonica 1981; 77(5): 511-20.
[4]
Mihara K, Matsumura M, Yoshioka E, et al. Intestinal first-pass metabolism of eperisone in the rat. Pharma Res 2001; 18(8): 1131-7.
[5]
Matsunaga M, Uemura Y, Yonemoto Y, et al. Long-lasting muscle relaxant activity of eperisone hydrochloride after percutaneous administration in rats. J Pharmacol Sci 1997; 73(3): 215-20.
[6]
Schäfer-Korting M, Mehnert W, Korting HC. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Reviews 2007; 59(6): 427-43.
[7]
Yang SI, Park HY, Lee SH, et al. Transdermal eperisone elicits more potent and longer-lasting muscle relaxation than oral eperisone. Pharmacol 2004; 71(3): 150-6.
[8]
Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol 2008; 26(11): 1261.
[9]
Kogan A, Garti N. Microemulsions as transdermal drug delivery vehicles. Adv Colloid Interface Sci 2006; 123: 369-85.
[10]
Schaefer H, Redelmeier TE. Skin barrier: principles of percutaneous absorption. 1st ed. Basel, Switzerland 1996; pp. 35-7.
[11]
Vicentini FT, Vaz MM, Fonseca YM, Bentley MV, Fonseca MJ. Characterization and stability study of a water-in-oil microemulsion incorporating quercetin. Drug Dev Ind Pharm 2011; 37(1): 47-55.
[12]
Shafiq-un-Nabi S, Shakeel F, Talegaonkar S, et al. Formulation development and optimization using nanoemulsion technique: a technical note. AAPS PharmSciTech 2007; 8(2): E12-7.
[13]
Sakeena MH, Muthanna FA, Ghassan ZA, et al. Formulation and in vitro evaluation of ketoprofen in palm oil esters nanoemulsion for topical delivery. J Oleo Sci 2010; 59(4): 223-8.
[14]
Zhang Y, Gao J, Zheng H, Zhang R, Han Y. The preparation of 3, 5-dihydroxy-4-isopropylstilbene nanoemulsion and in vitro release. Int J Nanomedicine 2011; 6: 649.
[15]
Neubert RH. Potentials of new nano carriers for dermal and transdermal drug delivery. Eur J Pharm Biopharm 2011; 77(1): 1-2.
[16]
Rhee YS, Choi JG, Park ES, Chi SC. Transdermal delivery of ketoprofen using microemulsions. Int J Pharma 2001; 228 1(2): 161-70.
[17]
Zhao X, Liu JP, Zhang X, Li Y. Enhancement of transdermal delivery of theophylline using microemulsion vehicle. Int J Pharma 2006; 327(2): 58-64.
[18]
Benson HA, Watkinson AC. Skin structure, function, and permeation Topical and transdermal drug delivery: principles and practice. John Wiley & Sons, Inc. 2012; pp. 409-46.
[19]
Avdeef A. Solubility of sparingly soluble ionizable drugs. Adv Drug Deliv Rev 2007; 59(7): 568-90.
[20]
Chen H, Chang X, Weng T, et al. A study of microemulsion systems for transdermal delivery of triptolide. J Control Release 2004; 98(3): 427-36.
[21]
Al-Adham IS, Ashour H, Al-Kaissi E, Khalil E, Kierans M, Collier PJ. Studies on the kinetics of killing and the proposed mechanism of action of microemulsions against fungi. Int J pharma 2013; 454(1): 226-32.
[22]
Baboota S, Al-Azaki A, Kohli K, Ali J, Dixit N, Shakeel F. Development and evaluation of a microemulsion formulation for transdermal delivery of terbinafine. PDA J Pharm Sci Technol 2007; 61(4): 276-85.
[23]
Jadhav KR, Shetye SL, Kadam VJ. Design and evaluation of microemulsion based drug delivery system. Int J Advances in Pharma Sci 2010; 1(2)
[24]
Okur NÜ, Yavaşoğlu A, Karasulu HY. Preparation and evaluation of microemulsion formulations of naproxen for dermal delivery. Chem Pharm Bull 2014; 62(2): 135-43.
[25]
Jain J, Fernandes C, Patravale V. Formulation development of parenteral phospholipid-based microemulsion of etoposide. Aaps PharmSciTech 2010; 11(2): 826-31.
[26]
Muthu MS, Singh S. Poly (D, L-lactide) nanosuspensions of risperidone for parenteral delivery: formulation and in-vitro evaluation. Curr Drug Deliv 2009; 6(1): 62-8.
[27]
Aggarwal N, Goindi S, Mehta SD. Preparation and evaluation of dermal delivery system of griseofulvin containing vitamin E-TPGS as penetration enhancer. AAPS PharmSciTech 2012; 13(1): 67-74.
[28]
Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev 2012; 64(1): 175-93.
[29]
Sharma N, Bansal M, Visht S, Sharma PK, Kulkarni GT. Nanoemulsion: A new concept of delivery system. Chron Young Sci 2010; 1(2): 2.
[30]
Farahpour MR, Habibi M. Evaluation of the wound healing activity of an ethanolic extract of Ceylon cinnamon in mice. Vet Med 2012; 57(1): 53-7.
[31]
Ridd MJ, Redmond NM, Hollinghurst S, et al. Choice of Moisturiser for Eczema Treatment (COMET): study protocol for a randomized controlled trial. Trials 2015; 16(1): 304.
[32]
Lachman L, Lieberman HA. Kanig M Martin Emulsions, in the theory and practice of industrial pharmacy Philadelphia. Lea & Febiger. New York 3rd ed.. 1990; pp. 1-909.
[33]
Tadros T. Principles of emulsion stabilization with special reference to polymeric surfactants. J Cosmet Sci 2006; 57(2): 153-69.
[34]
Teixeira GF, Vieira-Neto AE, da Costa FN, e Silva AR, Campos AR. Antinociceptive effect of (-)-α-bisabolol in nanocapsules. Biomed & Pharmaco 2017; 91: 946-50.
[35]
Mishra BK, Kuanar M, Chauhan G, Patel N. Behaviour of non-ionic Inicroe1nulsion containing Tween-80, iso-amyl alcohol, hexane and water. Indian J Chem Technol 2000; 7: 338-41.
[36]
Shi J, Xue SJ, Wang B, Wang W, Ye X, Quek SY. Optimization of formulation and influence of environmental stresses on stability of lycopene-microemulsion. LWT-Food Sci Techn 2015; 60(2): 999-1008.
[37]
Wakita K, Kuwabara H, Furusho N, Tatebe C, Sato K, Akiyama H. A comparative study of the hydroxyl and saponification values of polysorbate 60 in international food additive specifications. Am J Anal Chem 2014; 5(3): 199.
[38]
Bumajdad A, Eastoe J. Conductivity of water-in-oil microemulsions stabilized by mixed surfactants. J Colloid Interface Sci 2004; 274(1): 268-76.
[39]
Anjali CH, Dash M, Chandrasekaran N, Mukherjee A. Antibacterial activity of sunflower oil microemulsion. Int J Pharm Pharm Sci 2010; 2(1): 123-8.
[40]
Arshad AI, Khan SH, Akhtar NA. Formulation development of topical cream loaded with ananas comosus extract: in vivo evaluation for changes in skin barrier function using biophysical techniques. Acta Pol Pharm 2016; 73(2): 485-94.
[41]
Goldberg-Cettina M, Liu P, Nightingale J, Kurihara-Bergstrom T. Enhanced transdermal delivery of estradiol in vitro using binary vehicles of isopropyl myristate and short-chain alkanols. Int J Pharm 1995; 114(2): 237-45.
[42]
Chen H, Mou D, Du D, et al. Hydrogel-thickened microemulsion for topical administration of drug molecule at an extremely low concentration. Int J Pharma 2007; 341(1-2): 78-84.
[43]
Som I, Bhatia K, Yasir M. Status of surfactants as
penetration enhancers in transdermal drug delivery. J
Pharma bioallied sci 2012; 4(1) : 2.
6